PMID: 14514143Sep 30, 2003

Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden

Scandinavian Journal of Infectious Diseases
Jonas HedlundGöran Kronvall

Abstract

To investigate the serotype distribution and antibiotic susceptibility patterns 204 isolates of Streptococcus pneumoniae obtained from blood or cerebrospinal fluid (CSF) of children < or = 18 y of age were collected from 19 clinical microbiological laboratories in Sweden during the years 1998-2001. 166 isolates were from blood only, and 38 isolates were from CSF. The most common serotypes found were 6B, 1, 7F, 14, 18C, 19F, 6A, 4, 23F, 9V and 19A, in descending order of frequency. During the study period serotype 6B increased in frequency from 14.3% in 1998 to 28.3% in 2001 and serotype 1 decreased simultaneously from 20.4% to 9.4%. Serotype 1 was the most common serotype among children > or = 2 y of age or older, but was not found among children < 2 y of age. The potential coverage rate for the heptavalent pneumococcal conjugate vaccine varied between 53 and 68% during the studied years, and was higher for children < 2 y of age (74%) than for older children (51%). The majority of isolates were susceptible to penicillin and other antibiotics tested.

References

Dec 1, 1975·The Journal of Pediatrics·F A LodaF W Denny
Nov 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S V Nielsen, J Henrichsen
Nov 21, 1991·The New England Journal of Medicine·E D ShapiroJ D Clemens
Mar 1, 1985·Reviews of Infectious Diseases·L A BurmanBirger Trollfors
Oct 1, 1995·Journal of Clinical Microbiology·J Henrichsen
Jun 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J A ScottA Taunay
Jul 1, 1997·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·J C Butler
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·William P HausdorffG R Siber

Citations

Mar 17, 2007·Scandinavian Journal of Infectious Diseases·Erik BackhausKerstin Andersson
Oct 30, 2009·Expert Review of Vaccines·Roman Prymula, Lode Schuerman
Feb 26, 2016·Human Vaccines & Immunotherapeutics·William P Hausdorff, William P Hanage
Apr 15, 2017·Expert Review of Vaccines·Robert CohenCorinne Levy
Feb 11, 2005·The Pediatric Infectious Disease Journal·Helena KäyhtyLennart Nilsson
Sep 9, 2006·Epidemiology and Infection·E D G McIntoshM A Fletcher
Sep 2, 2008·Emerging Infectious Diseases·Ignacio ObandoAngela B Brueggemann

Related Concepts

Antibiotics
Fungus Drug Sensitivity Tests
Pneumococcal Infections
Probability
Serotyping
Streptococcus pneumoniae
Incidence Studies
Bacteremia
Bacterial Capsules
Multi-Drug Resistance

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.